Get startedLog in
    Picture of Annexon logo

    ANNX — Annexon News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapSucker Stock
    All News

    Annexon's neurological disorder drug meets main goal of late-stage study

    Picture of Annexon logoAnnexon
    04/06/2024 12:08
    June 4 (Reuters) - Annexon Inc  ANNX.O  said on Tuesday
its experimental drug to treat a rare neurological disorder met
the main goal of a late-stage trial.

 (Reporting by Sneha  S K; Editing by Shilpi Majumdar)
 ((Sneha.SK@thomsonreuters.com;))

    Recent news on Annexon

    See all news